AI ( artificialin obstetrics and gynaecology- for 10 mark question in dnb exam- reference from recent recommended updates- explain in simple language flowchart

Reading File
Finding Sources
Searching PubMed

"artificial intelligence" AND "obstetrics" AND "gynecology"

Searching the Web

artificial intelligence obstetrics gynaecology DNB exam 2024 2025 applications clinical uses

Reading Web Page

artificial intelligence obstetrics gynaecology applications clinical uses

Searching PubMed

"artificial intelligence" AND ("preeclampsia" OR "fetal monitoring" OR "CTG" OR "cervical cancer")

Now I have enough rich, current information to write a thorough DNB 10-mark answer with a flowchart. Let me compose it.

Artificial Intelligence in Obstetrics and Gynaecology

For DNB 10-Mark Answer | Updated to 2025

Quick Definition

Artificial Intelligence (AI) refers to computer systems that perform tasks requiring human intelligence - pattern recognition, prediction, decision-making - by learning from large datasets. In OB/GYN, AI tools include:
  • Machine Learning (ML) - algorithms that learn from data
  • Deep Learning (DL) / Neural Networks - multilayered models for image analysis
  • Natural Language Processing (NLP) - text/speech understanding
  • Convolutional Neural Networks (CNNs) - specialized for image classification

FLOWCHART: AI in Obstetrics and Gynaecology

                    ┌─────────────────────────────┐
                    │   AI IN OBSTETRICS & GYN     │
                    └─────────────┬───────────────┘
                                  │
        ┌─────────────────────────┼──────────────────────────┐
        │                         │                          │
        ▼                         ▼                          ▼
┌───────────────┐      ┌──────────────────┐       ┌──────────────────┐
│  OBSTETRICS   │      │   GYNAECOLOGY    │       │  REPRODUCTIVE    │
│               │      │                  │       │   MEDICINE       │
└──────┬────────┘      └────────┬─────────┘       └───────┬──────────┘
       │                        │                          │
       ▼                        ▼                          ▼
┌──────────────┐     ┌────────────────────┐    ┌────────────────────┐
│ 1. Prenatal  │     │ 4. Gynae Oncology  │    │ 7. IVF / ART       │
│    Imaging   │     │                    │    │                    │
│              │     │ • Cervical cancer  │    │ • Embryo grading   │
│ • Fetal      │     │   screening (AI    │    │   (AI selects best │
│   biometry   │     │   Pap/colposcopy)  │    │   embryo to        │
│   (auto-     │     │ • Ovarian mass     │    │   transfer)        │
│   measurement│     │   characterization │    │ • Sperm analysis   │
│   of BPD,    │     │   (IOTA+AI)        │    │ • Ovarian reserve  │
│   FL, AC)    │     │ • Endometrial      │    │   prediction       │
│              │     │   cancer staging   │    │                    │
│ • Anomaly    │     │                    │    └────────────────────┘
│   detection  │     └────────────────────┘
│   (neural    │
│   tube,      │     ┌────────────────────┐    ┌────────────────────┐
│   cardiac)   │     │ 5. Endometriosis   │    │ 8. Robotic         │
│              │     │                    │    │    Surgery         │
│ • Placenta   │     │ • Non-invasive     │    │                    │
│   localiz-   │     │   diagnosis using  │    │ • AI-guided        │
│   ation &    │     │   MRI+AI pattern   │    │   instruments      │
│   grading    │     │   recognition      │    │ • Real-time        │
└──────┬───────┘     └────────────────────┘    │   tissue           │
       │                                        │   identification   │
       ▼             ┌────────────────────┐    └────────────────────┘
┌──────────────┐     │ 6. Urogynaecology  │
│ 2. Fetal     │     │                    │
│  Monitoring  │     │ • Pelvic floor     │    ┌────────────────────┐
│  (CTG/KTG)   │     │   imaging (MRI/    │    │ 9. Telemedicine    │
│              │     │   ultrasound +AI)  │    │  & Remote Care     │
│ • AI-CTG     │     │ • Incontinence     │    │                    │
│   interpre-  │     │   classification   │    │ • Wearables for    │
│   tation     │     └────────────────────┘    │   fetal heart      │
│ • Reduces    │                               │   rate monitoring  │
│   false +ve  │                               │ • Gestational      │
│ • Predicts   │                               │   diabetes         │
│   fetal      │                               │   monitoring       │
│   distress   │                               └────────────────────┘
└──────┬───────┘
       │
       ▼
┌──────────────────┐
│ 3. Risk Prediction│
│   Models         │
│                  │
│ • Pre-eclampsia  │
│   (1st trimester │
│   MAP + uterine  │
│   artery RI +    │
│   PLGF + AI)     │
│ • Preterm birth  │
│ • GDM prediction │
│ • PPH risk       │
└──────────────────┘

Detailed Application - Domain by Domain

1. Prenatal Imaging and Ultrasound

AI uses CNNs trained on thousands of scans to:
  • Auto-measure fetal biometry (BPD, FL, HC, AC) - removes operator variability, saves 30-50% scan time
  • Detect anomalies - CNS defects (neural tube, ventriculomegaly) with ~96-97% accuracy; reduced false negatives by 97.5% in one study
  • Guide probe position - AI tells the sonographer in real-time when the correct standard plane is achieved (used in SonoSCOUT, GE Voluson AI)
  • 3D reconstruction of fetal face/heart from 2D sweeps
Reference: Ramirez Zegarra & Ghi, Ultrasound Obstet Gynecol, 2023 [PMID 36436205]

2. Fetal Heart Rate Monitoring (CTG / Cardiotocography)

This is a high-yield DNB topic:
CTG Trace Generated
       │
       ▼
AI Algorithm analyzes:
  - Baseline FHR
  - Variability patterns
  - Accelerations
  - Decelerations (types)
  - Contraction relationship
       │
       ▼
Classifies as:
  Normal / Suspicious / Pathological
       │
       ▼
Clinical Alert sent to OBstetrician
  (reduces inter-observer disagreement)
       │
       ▼
Decision: Continue labour / Expedite delivery
  • AI-CTG reduces unnecessary caesarean sections by reducing false-positive "non-reassuring" interpretations
  • Systems like Monica AN24, Oxford Medilog use AI for CTG analysis
  • Can predict fetal acidosis (pH <7.1) with higher accuracy than visual interpretation alone

3. First Trimester Risk Prediction (Pre-eclampsia, Preterm Birth)

11-13+6 weeks scan
         │
         ▼
AI Model inputs:
  ├── Maternal demographics (age, BMI, race)
  ├── Mean Arterial Pressure (MAP)
  ├── Uterine Artery Pulsatility Index (UtAPI)
  ├── Serum PLGF (Placental Growth Factor)
  └── Uterine PAPP-A
         │
         ▼
Risk Algorithm (FMF Combined Test)
  (Bayes' theorem + machine learning)
         │
         ▼
OUTPUT:
  ├── LOW RISK → Routine antenatal care
  └── HIGH RISK (>1:100) → Aspirin 150mg at night
              → Refer MFM
              → Doppler surveillance
  • Detection rate: ~75% for early-onset pre-eclampsia at 11-13 weeks (FMF model)
  • AI improves prediction by integrating non-linear relationships between biomarkers

4. Gynaecological Oncology - AI Applications

a) Cervical Cancer Screening

Cervical Sample / Colposcopy image
           │
           ▼
AI (Deep Learning CNN) analyzes:
  - Cell morphology (Pap smear)
  - Acetowhite patterns (VIA/VILI)
  - Colposcopy image features
           │
           ▼
Classifies: Normal / LSIL / HSIL / Cancer
           │
           ▼
Triage: Routine recall / Early treatment / Biopsy
  • WHO-supported AI tools for cervical screening in low-resource settings (e.g., PAVE study - WHO/NCI VIA AI project)
  • FDA-cleared: Hologic ThinPrep Imaging System uses AI for Pap smear analysis
  • Reduces workload on cytopathologists by 50-70%
Reference: Wu et al., Cancer Biol Med, 2024 [PMID 39297572]

b) Ovarian Mass Classification

Pelvic Ultrasound
       │
       ▼
IOTA (International Ovarian
Tumor Analysis) Rules + AI
       │
       ├── Simple Rules (SR)
       ├── ADNEX Model
       └── AI augmentation
              │
              ▼
Classification:
  Benign / Low-risk / High-risk malignancy
              │
              ▼
Management:
  Conservative / MDT / Surgery
  • AI-augmented IOTA-ADNEX model achieves AUC >0.95 for malignancy detection
  • Reduces unnecessary surgical referrals
Reference: Moro et al., Int J Cancer, 2024 - Systematic Review [PMID 38989809]

5. In-vitro Fertilization (IVF) and ART

Oocyte retrieval
       │
       ▼
Fertilization
       │
       ▼
Embryo Culture (Day 3 / Day 5)
       │
       ▼
AI-Timelapse Imaging (EmbryoScope)
  Analyzes:
    - Cell division timing (t2, t3, t5, tB)
    - Morphokinetics
    - Blastocyst expansion grade
       │
       ▼
AI Score: ViQi / KIDScore / iDAScore
       │
       ├── High Score → Priority transfer
       └── Low Score → Freeze / Discard
  • AI embryo selection improves live birth rates vs. conventional morphological grading
  • iDAScore (Vitrolife) and LifeWhisperer (Presagen) are FDA/CE-cleared AI embryo graders
  • AI sperm analysis (ISAS, SCA): motility, morphology, DNA fragmentation - more objective than manual count
Reference: Jiang & Bormann, Fertil Steril, 2023 [PMID 37211062]

6. Intrapartum Care

ApplicationWhat AI DoesBenefit
Labour progress monitoringAnalyses cervicogram + uterine contraction patternsPredicts arrested labour early
Intrapartum ultrasoundAuto-measures fetal head station, angle of progressionReduces failed instrumental delivery
Shoulder dystocia predictionReal-time EHR analysisEarlier preparation for manoeuvres
Postpartum haemorrhage riskPre-delivery ML risk scoreActivates PPH protocol earlier

7. Robotic Surgery - AI Integration

  • da Vinci system + AI: real-time tissue identification, haptic feedback simulation
  • AI assists in identifying ureters, vessels during laparoscopic hysterectomy (prevents inadvertent injury)
  • Augmented reality overlay - visualises structures during myomectomy, endometriosis excision
  • Reduces operative time and conversion rates in complex cases

8. Telemedicine and Remote Monitoring

  • Wearable CTG devices (e.g., Monica AN24 patch) transmit FHR to AI platform - allows home monitoring of high-risk pregnancies
  • AI chatbots for antenatal triage (FLORENCE, WHO)
  • Gestational diabetes apps - continuous glucose monitoring + AI dietary advice
  • Blood pressure AI apps - detect hypertension in pregnancy remotely

9. Ethical and Practical Challenges (Important for DNB!)

CHALLENGES OF AI IN OB/GYN
           │
     ┌─────┴──────┐
     │            │
  Clinical      Ethical
     │            │
  • Algorithm  • Data privacy
    bias (if     (patient
    trained      consent)
    on non-    • Algorithmic
    diverse      bias (under-
    data)        representation
  • Black-box    of minorities)
    problem    • Liability
  • Integration  (who is
    into EHR     responsible
    workflow     if AI errs?)
  • Training   • Equity of
    clinicians   access
  • Regulation
    (FDA 510k /
    CE marking)

10. Regulatory Framework

  • FDA (USA): AI/ML-based Software as Medical Device (SaMD) - 510(k) or De Novo pathway
  • CE marking (Europe): Medical Device Regulation (MDR 2017/745)
  • India: CDSCO regulates AI-based medical devices under Medical Devices Rules 2017 (amended 2020)
  • AI tools are classified as Class II or III depending on risk to patient

Summary Table for Quick Revision

DomainAI ApplicationKey Tool/System
Prenatal USGAuto-biometry, anomaly detectionSonoSCOUT, Voluson AI
Fetal monitoringCTG interpretationMonica AN24, Oxford Medilog
Risk predictionPre-eclampsia, pretermFMF Combined test
Cervical screeningPap AI, colposcopyHologic ThinPrep, VIA AI
Ovarian massMalignancy riskIOTA-ADNEX + AI
IVFEmbryo selectioniDAScore, LifeWhisperer
Intrapartum USGHead station angleIntrapartum AI
Robotic surgeryTissue ID, navigationda Vinci AI
Remote careWearable FHR, GDM appsMonica patch

Model DNB Answer Format (10 Marks)

Introduction (1 mark): Define AI; mention ML, DL, NLP; state rapid growth in OB/GYN.
Obstetric applications (3 marks): Prenatal imaging + anomaly detection; CTG interpretation; first trimester risk prediction (pre-eclampsia, preterm birth); intrapartum AI.
Gynaecological applications (3 marks): Cervical screening; ovarian mass classification (IOTA-ADNEX); endometrial cancer; endometriosis; robotic surgery.
Reproductive medicine (1 mark): Embryo grading in IVF; sperm analysis.
Challenges and ethics (1 mark): Bias, black box, liability, equity, regulation.
Future directions + conclusion (1 mark): Personalised medicine, genomics integration, telemedicine, global health equity.

Key References:
  • Ramirez Zegarra R & Ghi T. AI in fetal ultrasound. Ultrasound Obstet Gynecol 2023 [PMID 36436205]
  • Horgan R et al. AI in obstetric ultrasound - scoping review. Prenat Diagn 2023 [PMID 37503802]
  • Jiang VS & Bormann CL. AI in IVF laboratory. Fertil Steril 2023 [PMID 37211062]
  • Moro F et al. AI in gynaecologic oncology ultrasound - systematic review. Int J Cancer 2024 [PMID 38989809]
  • Wu T et al. AI in cervical cancer screening. Cancer Biol Med 2024 [PMID 39297572]
  • PMC 12303583. AI in Obstetrics and Gynaecology - comprehensive review 2025
This is a shared conversation. Sign in to Orris to start your own chat.